patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Today's trading
Pluristem's 2nd pre-clinical study in ischemic strokes show statistically significant advantages in functional and anatomical recovery.
Share
New Message
Please login to post a reply